Geoff Brooke
Fortune : 879 954 $ au 31/05/2026
Fortune : 879 954 $ au 31/05/2026
Geoff Edward Duncan Brooke was the founder of GBS Venture Partners Pty Ltd. (founded in 1996) where the title held was Managing Partner.
Dr. Brooke was the founder of MedVest, Inc. (founded in 1996) where the title held was President.
Dr. Brooke is the founder of Actinogen Medical Ltd. (founded in 1999) where the title held is Independent Non-Executive Chairman.
Current jobs include Independent Non-Executive Chairman at Cynata Therapeutics Ltd. since 2020, Director at OcuNexus Therapeutics, Inc., Non-Executive Director at ChemGenex Pharmaceuticals, Inc., Independent Non-Executive Director at Acrux Ltd. since 2016, Director at Cerylid Biosciences Ltd., Director at CoDa Therapeutics (NZ) Ltd., Independent Non-Executive Director at Prevatex Pty Ltd., Non-Executive Director at Saluda Medical, Inc. since 2020, and Senior Partner at Bioscience Managers Pty Ltd.Former jobs include Director at Cogstate Ltd., Non-Executive Director at Nuwellis, Inc. from 2002 to 2011, Director at Uptake Medical Corp., Director at Antipodean Pharmaceuticals, Inc., Independent Non-Executive Director at ChemGenex Pharmaceuticals Pty Ltd. in 2011, Independent Director at Victorian WorkCover Authority from 2009 to 2015, Director at Promix Pty Ltd., Director at Phenomix Australia Pty Ltd., and Non-Executive Director at Health.com.au Pty Ltd.Education history includes undergraduate studies at the University of Melbourne and an MBA from the International Institute for Management Development.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 26/03/2026 | 29 879 929 ( 0,82% ) | 816 917 $ | 31/05/2026 | |
| 30/06/2025 | 312 898 ( 0,13% ) | 63 036 $ | 31/05/2026 | |
| 05/12/2025 | 0 ( -.--% ) | - $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| ACRUX LIMITED | Directeur/Membre du Conseil | 01/06/2016 |
| ACTINOGEN MEDICAL LIMITED | Fondateur | 23/03/1999 |
| CYNATA THERAPEUTICS LIMITED | Président | 18/08/2020 |
| SALUDA MEDICAL, INC. | Directeur/Membre du Conseil | 01/10/2020 |
Bioscience Managers Pty Ltd.
Bioscience Managers Pty Ltd. Investment ManagersFinance Bioscience Managers invests in both public and private companies located in Asia, Australia and New Zealand. The firm focuses on healthcare and life sciences sectors. It participates in early and growth stage capital transactions. | Private Equity Investor | - |
Prevatex Pty Ltd.
Prevatex Pty Ltd. BiotechnologyHealth Technology Engages in research and development of probiotic-based biotherapeutics | Directeur/Membre du Conseil | - |
ChemGenex Pharmaceuticals, Inc.
ChemGenex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and develops pharmaceuticals | Directeur/Membre du Conseil | 03/06/2011 |
Cerylid Biosciences Ltd.
Cerylid Biosciences Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Directeur/Membre du Conseil | 17/03/2011 |
OcuNexus Therapeutics, Inc.
OcuNexus Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Develops, commercializes and manufactures therapeutic products for clinical ophthalmology | Directeur/Membre du Conseil | 25/03/2010 |
| ░░░░ ░░░░░░░░░░░░ ░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | - |
| Sociétés | Poste | Fin |
|---|---|---|
| ░░░░░░░░░ ░░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ ░░░░░░░░░░░░░░░ ░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░ ░░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | - |
| ░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 23 |
|---|---|
Cogstate Ltd.
Cogstate Ltd. Miscellaneous Commercial ServicesCommercial Services Engages in creation, validation and commercialization of digital brain health assessments & tools | Commercial Services |
Nuwellis, Inc.
Nuwellis, Inc. Medical SpecialtiesHealth Technology Develops heart assist devices | Health Technology |
Uptake Medical Corp.
Uptake Medical Corp. Medical SpecialtiesHealth Technology Develops medical technologies for the treatment of lung diseases | Health Technology |
Antipodean Pharmaceuticals, Inc.
Antipodean Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products and provides pre clinical services | Health Technology |
OcuNexus Therapeutics, Inc.
OcuNexus Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Develops, commercializes and manufactures therapeutic products for clinical ophthalmology | Commercial Services |
ChemGenex Pharmaceuticals Pty Ltd.
ChemGenex Pharmaceuticals Pty Ltd. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Victorian WorkCover Authority
Victorian WorkCover Authority General GovernmentGovernment Administers occupational health, safety, compensation and welfare laws in Victoria | Government |
University of Melbourne
University of Melbourne Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ChemGenex Pharmaceuticals, Inc.
ChemGenex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and develops pharmaceuticals | Health Technology |
Acrux Ltd.
Acrux Ltd. Pharmaceuticals: MajorHealth Technology Develops and commercializes pharmaceutical products | Health Technology |
Cerylid Biosciences Ltd.
Cerylid Biosciences Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
GBS Venture Partners Pty Ltd.
GBS Venture Partners Pty Ltd. Investment ManagersFinance GBS Venture Partner seeks investment opportunities in private and public companies located in the United States, New Zealand and primarily in Australia. The firm targets companies operating in the fields of human healthcare, biotechnology, life science, biological/small molecule therapeutics, medical devices and diagnostics. It provides financing for seed, early and later stage capital requirements with an investment size ranging from of USD 10 to 12 million. It takes an active role on the board of directors and acts as a lead investor. It also makes co-investments. | Finance |
International Institute for Management Development
International Institute for Management Development Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Promix Pty Ltd.
Promix Pty Ltd. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals and researches medical diagnostic products | Health Technology |
MedVest, Inc. | |
CoDa Therapeutics (NZ) Ltd.
CoDa Therapeutics (NZ) Ltd. Pharmaceuticals: MajorHealth Technology Develops and markets biopharmaceutical products | Health Technology |
Actinogen Medical Ltd.
Actinogen Medical Ltd. Pharmaceuticals: OtherHealth Technology Manufactures and develops biotechnology compounds | Health Technology |
Cynata Therapeutics Ltd.
Cynata Therapeutics Ltd. BiotechnologyHealth Technology Engages in stem cell research and development services | Health Technology |
Phenomix Australia Pty Ltd. | |
Bioscience Managers Pty Ltd.
Bioscience Managers Pty Ltd. Investment ManagersFinance Bioscience Managers invests in both public and private companies located in Asia, Australia and New Zealand. The firm focuses on healthcare and life sciences sectors. It participates in early and growth stage capital transactions. | Finance |
Health.com.au Pty Ltd.
Health.com.au Pty Ltd. Life/Health InsuranceFinance Provides health insurance services | Finance |
Saluda Medical, Inc.
Saluda Medical, Inc. Medical SpecialtiesHealth Technology Manufactures medical devices that develops treatments for neurological problems | Health Technology |
Prevatex Pty Ltd.
Prevatex Pty Ltd. BiotechnologyHealth Technology Engages in research and development of probiotic-based biotherapeutics | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national